The pathogenetic role of antibodies against MuSK has been demonstrated in a passive transfer animal model with immunoglobulins isolated from the serum of MG patients or with recombinant antibodies isolated from B or plasma cells isolated from the periphery of MG patients. This evidence concerns the gene MUSK and myasthenia gravis.